Candriam SCA’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-372,204
| Closed | -$26.6M | – | 664 |
|
|
2023
Q2 | $26.6M | Sell |
372,204
-235,847
| -39% | -$16.9M | 0.19% | 132 |
|
|
2023
Q1 | $38.8M | Buy |
608,051
+9,508
| +2% | +$607K | 0.27% | 90 |
|
|
2022
Q4 | $40.6M | Sell |
598,543
-11,484
| -2% | -$779K | 0.27% | 86 |
|
|
2022
Q3 | $33.5M | Sell |
610,027
-34,105
| -5% | -$1.87M | 0.24% | 98 |
|
|
2022
Q2 | $42.6M | Sell |
644,132
-233,728
| -27% | -$15.4M | 0.35% | 68 |
|
|
2022
Q1 | $58.2M | Sell |
877,860
-183,350
| -17% | -$12.2M | 0.4% | 61 |
|
|
2021
Q4 | $61.8M | Buy |
1,061,210
+32,777
| +3% | +$1.91M | 0.39% | 58 |
|
|
2021
Q3 | $61.8M | Buy |
1,028,433
+771,047
| +300% | +$46.3M | 0.42% | 54 |
|
|
2021
Q2 | $15.4M | Buy |
257,386
+93,802
| +57% | +$5.62M | 0.11% | 225 |
|
|
2021
Q1 | $7.86M | Buy |
163,584
+116
| +0.1% | +$5.57K | 0.07% | 294 |
|
|
2020
Q4 | $8.17M | Buy |
163,468
+44,363
| +37% | +$2.22M | 0.06% | 302 |
|
|
2020
Q3 | $6.53M | Buy |
119,105
+64,419
| +118% | +$3.53M | 0.06% | 310 |
|
|
2020
Q2 | $2.89M | Sell |
54,686
-45,393
| -45% | -$2.4M | 0.03% | 426 |
|
|
2020
Q1 | $4.88M | Buy |
100,079
+63
| +0.1% | +$3.07K | 0.05% | 353 |
|
|
2019
Q4 | $4.99M | Buy |
+100,016
| New | +$4.99M | 0.05% | 360 |
|
|
2018
Q1 | – | Sell |
-21,200
| Closed | -$736K | – | 765 |
|
|
2017
Q4 | $736K | Sell |
21,200
-13,676
| -39% | -$475K | 0.01% | 629 |
|
|
2017
Q3 | $1.18M | Sell |
34,876
-804
| -2% | -$27.2K | 0.02% | 544 |
|
|
2017
Q2 | $1.22M | Hold |
35,680
| – | – | 0.02% | 547 |
|
|
2017
Q1 | $1.11M | Hold |
35,680
| – | – | 0.02% | 548 |
|
|
2016
Q4 | $975K | Hold |
35,680
| – | – | 0.02% | 520 |
|
|
2016
Q3 | $1.17M | Sell |
35,680
-4,320
| -11% | -$142K | 0.03% | 465 |
|
|
2016
Q2 | $1.21M | Buy |
+40,000
| New | +$1.21M | 0.03% | 398 |
|